GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Inventory Turnover

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Inventory Turnover : 4.03 (As of Dec. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Parnell Pharmaceuticals Holdings's Cost of Goods Sold for the six months ended in Dec. 2018 was $7.90 Mil. Parnell Pharmaceuticals Holdings's Average Total Inventories for the quarter that ended in Dec. 2018 was $1.96 Mil. Parnell Pharmaceuticals Holdings's Inventory Turnover for the quarter that ended in Dec. 2018 was 4.03.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Parnell Pharmaceuticals Holdings's Days Inventory for the six months ended in Dec. 2018 was 45.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Parnell Pharmaceuticals Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2018 was 0.10.


Parnell Pharmaceuticals Holdings Inventory Turnover Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Inventory Turnover Chart

Parnell Pharmaceuticals Holdings Annual Data
Trend Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Inventory Turnover
Get a 7-Day Free Trial 3.26 2.57 2.56 3.47 4.03

Parnell Pharmaceuticals Holdings Semi-Annual Data
Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Inventory Turnover Get a 7-Day Free Trial 3.19 2.57 2.56 3.47 4.03

Parnell Pharmaceuticals Holdings Inventory Turnover Calculation

Parnell Pharmaceuticals Holdings's Inventory Turnover for the fiscal year that ended in Dec. 2018 is calculated as

Inventory Turnover (A: Dec. 2018 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2018 ) / ((Total Inventories (A: Dec. 2017 ) + Total Inventories (A: Dec. 2018 )) / count )
=7.903 / ((1.633 + 2.29) / 2 )
=7.903 / 1.9615
=4.03

Parnell Pharmaceuticals Holdings's Inventory Turnover for the quarter that ended in Dec. 2018 is calculated as

Inventory Turnover (Q: Dec. 2018 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2018 ) / ((Total Inventories (Q: Dec. 2017 ) + Total Inventories (Q: Dec. 2018 )) / count )
=7.903 / ((1.633 + 2.29) / 2 )
=7.903 / 1.9615
=4.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnell Pharmaceuticals Holdings  (OTCPK:PARNF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Parnell Pharmaceuticals Holdings's Days Inventory for the six months ended in Dec. 2018 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2018 )/Cost of Goods Sold (Q: Dec. 2018 )*Days in Period
=1.9615/7.903*365 / 2
=45.30

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Parnell Pharmaceuticals Holdings's Inventory to Revenue for the quarter that ended in Dec. 2018 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2018 ) / Revenue (Q: Dec. 2018 )
=1.9615 / 19.031
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Parnell Pharmaceuticals Holdings Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.